NO975773L - Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved - Google Patents

Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved

Info

Publication number
NO975773L
NO975773L NO975773A NO975773A NO975773L NO 975773 L NO975773 L NO 975773L NO 975773 A NO975773 A NO 975773A NO 975773 A NO975773 A NO 975773A NO 975773 L NO975773 L NO 975773L
Authority
NO
Norway
Prior art keywords
substances
dry
methods
compositions obtained
foamed glass
Prior art date
Application number
NO975773A
Other languages
English (en)
Norwegian (no)
Other versions
NO975773D0 (no
Inventor
Bruce Joseph Roser
Enda Martin Gribbon
Original Assignee
Quadrant Holdings Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975773(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadrant Holdings Cambridge filed Critical Quadrant Holdings Cambridge
Publication of NO975773D0 publication Critical patent/NO975773D0/no
Publication of NO975773L publication Critical patent/NO975773L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO975773A 1995-06-07 1997-12-08 Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved NO975773L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07
PCT/GB1996/001367 WO1996040077A2 (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Publications (2)

Publication Number Publication Date
NO975773D0 NO975773D0 (no) 1997-12-08
NO975773L true NO975773L (no) 1998-02-03

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975773A NO975773L (no) 1995-06-07 1997-12-08 Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved

Country Status (22)

Country Link
EP (1) EP0831790B1 (zh)
JP (1) JP4502406B2 (zh)
KR (1) KR19990022710A (zh)
CN (1) CN1245957C (zh)
AP (1) AP852A (zh)
AT (1) ATE239451T1 (zh)
AU (1) AU713599B2 (zh)
BR (1) BR9609188A (zh)
CA (1) CA2223438C (zh)
CZ (1) CZ391297A3 (zh)
DE (1) DE69628007T2 (zh)
DK (1) DK0831790T3 (zh)
ES (1) ES2194992T3 (zh)
HU (1) HUP9901716A3 (zh)
IL (1) IL122482A (zh)
MX (1) MX9709716A (zh)
NO (1) NO975773L (zh)
NZ (1) NZ309841A (zh)
PL (1) PL184823B1 (zh)
PT (1) PT831790E (zh)
SK (1) SK167597A3 (zh)
WO (1) WO1996040077A2 (zh)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033488A1 (en) 1994-06-02 1995-12-14 Quadrant Holdings Cambridge Limited Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
KR20010032550A (ko) * 1997-11-26 2001-04-25 유니버설 프리저베이션 테크놀로지스 인코포레이티드 유리화에 의한 민감한 생물학적 시료의 보존방법
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1071465A1 (en) * 1998-03-18 2001-01-31 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
EA004131B1 (ru) * 1999-05-04 2003-12-25 Энхайдро Лимитед Способ сохранения вирусов и микоплазмы
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
EP1402003A4 (en) * 1999-08-19 2004-07-14 Universal Preservation Technologies Inc STORAGE OF AMBIENT TEMPERATURE BACTERIAL CELLS
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1296656B1 (en) 2000-06-27 2006-08-02 F. Hoffmann-La Roche Ag Method for preparing a composition
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
WO2003041637A2 (en) * 2001-11-09 2003-05-22 Centocor, Inc. Lyophilized monoclonal antibody compositions
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
LT2395073T (lt) 2002-11-01 2017-11-10 Glaxosmithkline Biologicals S.A. Džiovinimo būdas
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
CA2567720A1 (en) * 2004-05-24 2005-12-08 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form
US9469835B2 (en) 2004-06-02 2016-10-18 Victor Bronshtein Preservation by vaporization
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
DK1973406T3 (da) * 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
BRPI0814594A2 (pt) 2007-07-26 2015-01-20 Sanofi Pasteur Ltd Composições e métodos adjuvantes de antígeno
CN102177237B (zh) 2008-09-12 2013-10-30 金沃特公司 用于贮存和稳定生物分子的基质和介质
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
CN106987525B (zh) 2009-05-26 2020-10-27 先进生物营养公司 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
JP5727611B2 (ja) * 2010-08-13 2015-06-03 アドバンスド バイオニュートリション コーポレイション 生体物質用の乾燥貯蔵安定化組成物
RU2013143149A (ru) * 2011-02-24 2015-03-27 Пэксвэкс, Инк. Составы, пригодные для вакцин, получаемых сушкой распылением
CA2836273C (en) * 2011-05-17 2019-01-15 Soligenix, Inc. Thermostable vaccine compositions and methods of preparing same
EP4088736A1 (en) 2011-10-25 2022-11-16 Prothena Biosciences Limited Humanized anti-amyloid antibody formulations and methods
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
CN108347982A (zh) 2015-07-29 2018-07-31 高级生物营养公司 用于特殊饮食用途的稳定的干燥益生菌组合物
EP3754011B1 (en) * 2015-09-09 2022-02-16 Drawbridge Health, Inc. Devices for sample collection, stabilization and preservation
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
CN115251923A (zh) 2017-01-10 2022-11-01 集联健康有限公司 用于样品收集的装置、系统和方法
CN118086244A (zh) * 2023-08-18 2024-05-28 北京中检葆泰生物技术有限公司 一种乳源碱性磷酸酶标准品的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
EP0166440A3 (en) * 1984-06-28 1987-06-03 THE PROCTER & GAMBLE COMPANY Antacid composition
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
JP3016096B2 (ja) * 1989-05-01 2000-03-06 バクスター インターナショナル インコーポレーテッド 有益な薬剤から成る組成物および制御された溶解により該組成物を投与する方法
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
DK0615438T3 (da) * 1991-12-05 1996-11-11 Mallinckrodt Veterinary Inc En carbohydratglasmatrix til langvarig frigivelse af et terapeutisk middel
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
JPH10500982A (ja) * 1994-05-27 1998-01-27 ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ 医薬組成物

Also Published As

Publication number Publication date
ATE239451T1 (de) 2003-05-15
WO1996040077A3 (en) 1997-01-23
WO1996040077A2 (en) 1996-12-19
JPH11506467A (ja) 1999-06-08
CA2223438C (en) 2008-05-13
DE69628007T2 (de) 2003-11-27
IL122482A0 (en) 1998-06-15
KR19990022710A (ko) 1999-03-25
PT831790E (pt) 2003-07-31
HUP9901716A2 (hu) 1999-09-28
BR9609188A (pt) 1999-05-11
PL323902A1 (en) 1998-04-27
PL184823B1 (pl) 2002-12-31
DE69628007D1 (de) 2003-06-12
CN1245957C (zh) 2006-03-22
EP0831790B1 (en) 2003-05-07
IL122482A (en) 1999-10-28
HUP9901716A3 (en) 2000-04-28
NO975773D0 (no) 1997-12-08
MX9709716A (es) 1998-03-31
AP852A (en) 2000-06-16
CZ391297A3 (cs) 1998-05-13
AP9701151A0 (en) 1998-01-31
DK0831790T3 (da) 2003-09-01
EP0831790A2 (en) 1998-04-01
AU713599B2 (en) 1999-12-09
CN1193908A (zh) 1998-09-23
CA2223438A1 (en) 1996-12-19
JP4502406B2 (ja) 2010-07-14
ES2194992T3 (es) 2003-12-01
SK167597A3 (en) 1998-10-07
NZ309841A (en) 1999-10-28
AU6009896A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
NO975773L (no) Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved
DE68919911D1 (de) Chlordioxyd enthaltende Zusammensetzungen und ihre Herstellung.
DE69721151D1 (de) Kieselsäuregefüllte Kautschukzusammensetzungen und ihre Herstellung
AU7482396A (en) Substituted aryl pyrroles, compositions containing such compounds and methods of use
NO983592L (no) Blandinger avledet fra korn av Eugénia Jambolana Lamarck, fremstilling og bruk av blandingene og noen av deres bestanddeler
AU7529096A (en) Substituted aryl pyrroles, compositions containing such compounds and methods of use
NO894173D0 (no) Fremgangsmaate ved fremstilling av kloridoksid.
NO992504D0 (no) Sammensetninger for behandling av jord, fremgangsmÕte for fremstilling derav, samt anvendelse
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
NO912048D0 (no) Belegg- og impregneringssammensetning og fremgangsmaate ved anvendelse av denne.
BR9708248A (pt) Benzotiofenos formulações contendo os mesmos e metódos
NO308251B1 (no) Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
DE69602903D1 (de) Herstellung von Glaszusammensetzungen
AU7986098A (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
DE68914700D1 (de) Polymere Zusammensetzungen und ihre Herstellung.
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
WO1999061598A3 (en) Lentiviral vector compositions and methods of use
AU1259097A (en) Dry foamable composition and uses thereof
DE69730766D1 (de) Maltooligosyltaranose und Maltooligosylparatinose enthaltende Polysaccharidzusammensetzung, Herstellung und Verwendung
FI964829A (fi) Menetelmä 2,2,4-trimetyyli-1,3-pentaanidioli-isobutyraatin valmistamiseksi
AU8682798A (en) High fructose containing insecticide compositions and methods of using the same
DE69737529D1 (de) Herstellung von 1-butyl-4-piperidinylmethylamin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application